Opioids

Proposed in-person visit requirements raises concern for psychiatry groups

New tech can have unforeseen consequences if it improperly flags patients or doctors

More than 80% of patients completed screening in the first 30 days

News and commentary from the world of neurology and neuroscience

Strategy involves a "whole-of-government" response, says Rahul Gupta

Australian trial finds no difference in pain scores over 6 weeks

Almost all procedures had an increase in both types of prescribing, Medicare data showed

A Narcan kind of weekend

OTC agents are not safe alternatives to prescription opioids, study suggests

In non-responsive patients, think polysubstance use, says addiction treatment expert Kelly Ramsey

But critics say the HALT Fentanyl Act is the wrong way to approach the problem

Longer-acting nasal spray to be available by end of the year

It comes down to funding -- but it's time for that to change

Suicide prevention in traumatic brain injury survivors also on the docket during hearing